Katherine A. Hajjar - Publications

Affiliations: 
Weill Cornell Medical College, New York, NY, United States 
Area:
Cell Biology, Neuroscience Biology, Molecular Biology

95 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Morozova K, Sridhar S, Zolla V, Clement CC, Scharf B, Verzani Z, Diaz A, Larocca JN, Hajjar KA, Cuervo AM, Santambrogio L. Corrigendum: Annexin A2 promotes phagophore assembly by enhancing Atg16⁺ vesicle biogenesis and homotypic fusion. Nature Communications. 6: 6816. PMID 25817270 DOI: 10.1038/ncomms7816  0.72
2015 Morozova K, Sidhar S, Zolla V, Clement CC, Scharf B, Verzani Z, Diaz A, Larocca JN, Hajjar KA, Cuervo AM, Santambrogio L. Annexin A2 promotes phagophore assembly by enhancing Atg16L⁺ vesicle biogenesis and homotypic fusion. Nature Communications. 6: 5856. PMID 25597631 DOI: 10.1038/ncomms6856  0.72
2015 Chapin JC, Hajjar KA. Fibrinolysis and the control of blood coagulation. Blood Reviews. 29: 17-24. PMID 25294122 DOI: 10.1016/j.blre.2014.09.003  0.72
2014 Bambino K, Lacko LA, Hajjar KA, Stuhlmann H. Epidermal growth factor-like domain 7 is a marker of the endothelial lineage and active angiogenesis. Genesis (New York, N.Y. : 2000). 52: 657-70. PMID 24740971 DOI: 10.1002/dvg.22781  0.72
2014 Dassah M, Almeida D, Hahn R, Bonaldo P, Worgall S, Hajjar KA. Annexin A2 mediates secretion of collagen VI, pulmonary elasticity and apoptosis of bronchial epithelial cells. Journal of Cell Science. 127: 828-44. PMID 24357721 DOI: 10.1242/jcs.137802  0.72
2013 Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, Almeida D, Koller A, Hajjar KA, Stainier DY, Chen EI, Lyden D, Bissell MJ. The perivascular niche regulates breast tumour dormancy. Nature Cell Biology. 15: 807-17. PMID 23728425 DOI: 10.1038/ncb2767  0.72
2013 Ruan J, Luo M, Wang C, Fan L, Yang SN, Cardenas M, Geng H, Leonard JP, Melnick A, Cerchietti L, Hajjar KA. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes. Blood. 121: 5192-202. PMID 23632889 DOI: 10.1182/blood-2013-03-490763  0.72
2013 Dai H, Yu Z, Fan X, Liu N, Yan M, Chen Z, Lo EH, Hajjar KA, Wang X. Dysfunction of annexin A2 contributes to hyperglycaemia-induced loss of human endothelial cell surface fibrinolytic activity. Thrombosis and Haemostasis. 109: 1070-8. PMID 23572070 DOI: 10.1160/TH12-12-0944  0.72
2013 Luo M, Hajjar KA. Annexin A2 system in human biology: cell surface and beyond. Seminars in Thrombosis and Hemostasis. 39: 338-46. PMID 23483454 DOI: 10.1055/s-0033-1334143  0.72
2012 Hedhli N, Falcone DJ, Huang B, Cesarman-Maus G, Kraemer R, Zhai H, Tsirka SE, Santambrogio L, Hajjar KA. The annexin A2/S100A10 system in health and disease: Emerging paradigms Journal of Biomedicine and Biotechnology. 2012. PMID 23193360 DOI: 10.1155/2012/406273  0.72
2012 Seidah NG, Poirier S, Denis M, Parker R, Miao B, Mapelli C, Prat A, Wassef H, Davignon J, Hajjar KA, Mayer G. Annexin A2 is a natural extrahepatic inhibitor of the PCSK9-induced LDL receptor degradation. Plos One. 7: e41865. PMID 22848640 DOI: 10.1371/journal.pone.0041865  0.72
2012 Scharf B, Clement CC, Wu XX, Morozova K, Zanolini D, Follenzi A, Larocca JN, Levon K, Sutterwala FS, Rand J, Cobelli N, Purdue E, Hajjar KA, Santambrogio L. Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris. Nature Communications. 3: 755. PMID 22453828 DOI: 10.1038/ncomms1754  0.72
2011 Zhai H, Acharya S, Gravanis I, Mehmood S, Seidman RJ, Shroyer KR, Hajjar KA, Tsirka SE. Annexin A2 promotes glioma cell invasion and tumor progression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 14346-60. PMID 21976520 DOI: 10.1523/JNEUROSCI.3299-11.2011  0.72
2011 Huang B, Deora AB, He KL, Chen K, Sui G, Jacovina AT, Almeida D, Hong P, Burgman P, Hajjar KA. Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice. Blood. 118: 2918-29. PMID 21788340 DOI: 10.1182/blood-2011-03-341214  0.72
2011 Upmacis RK, Shen H, Benguigui LE, Lamon BD, Deeb RS, Hajjar KA, Hajjar DP. Inducible nitric oxide synthase provides protection against injury-induced thrombosis in female mice. American Journal of Physiology. Heart and Circulatory Physiology. 301: H617-24. PMID 21602468 DOI: 10.1152/ajpheart.00667.2010  0.72
2011 Flood EC, Hajjar KA. The annexin A2 system and vascular homeostasis. Vascular Pharmacology. 54: 59-67. PMID 21440088 DOI: 10.1016/j.vph.2011.03.003  0.72
2011 Cesarman-Maus G, Cantú-Brito C, Barinagarrementeria F, Villa R, Reyes E, Sanchez-Guerrero J, Hajjar KA, Latorre EG. Autoantibodies against the fibrinolytic receptor, annexin A2, in cerebral venous thrombosis. Stroke; a Journal of Cerebral Circulation. 42: 501-3. PMID 21193750 DOI: 10.1161/STROKEAHA.110.592121  0.72
2011 He KL, Sui G, Xiong H, Broekman MJ, Huang B, Marcus AJ, Hajjar KA. Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2. The Journal of Biological Chemistry. 286: 15428-39. PMID 21115493 DOI: 10.1074/jbc.M110.185058  0.72
2011 Sarkar S, Swiercz R, Kantara C, Hajjar KA, Singh P. Annexin A2 mediates up-regulation of NF-κB, β-catenin, and stem cell in response to progastrin in mice and HEK-293 cells. Gastroenterology. 140: 583-595.e4. PMID 20826156 DOI: 10.1053/j.gastro.2010.08.054  0.72
2010 Fan X, Yu Z, Liu J, Liu N, Hajjar KA, Furie KL, Lo EH, Wang X. Annexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy. Stroke; a Journal of Cerebral Circulation. 41: S54-8. PMID 20876506 DOI: 10.1161/STROKEAHA.110.596106  0.72
2010 Ruan J, Martin P, Coleman M, Furman RR, Cheung K, Faye A, Elstrom R, Lachs M, Hajjar KA, Leonard JP. Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma. Cancer. 116: 2655-64. PMID 20235190 DOI: 10.1002/cncr.25055  0.72
2010 Zhu H, Fan X, Yu Z, Liu J, Murata Y, Lu J, Zhao S, Hajjar KA, Lo EH, Wang X. Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 30: 1137-46. PMID 20068577 DOI: 10.1038/jcbfm.2009.279  0.72
2009 Dassah M, Deora AB, He K, Hajjar KA. The endothelial cell annexin A2 system and vascular fibrinolysis. General Physiology and Biophysics. 28: F20-8. PMID 20093722  0.72
2009 Jacovina AT, Deora AB, Ling Q, Broekman MJ, Almeida D, Greenberg CB, Marcus AJ, Smith JD, Hajjar KA. Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. The Journal of Clinical Investigation. 119: 3384-94. PMID 19841537 DOI: 10.1172/JCI39591  0.72
2009 Romay-Penabad Z, Montiel-Manzano MG, Shilagard T, Papalardo E, Vargas G, Deora AB, Wang M, Jacovina AT, Garcia-Latorre E, Reyes-Maldonado E, Hajjar KA, Pierangeli SS. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood. 114: 3074-83. PMID 19628708 DOI: 10.1182/blood-2008-11-188698  0.72
2009 Law AL, Ling Q, Hajjar KA, Futter CE, Greenwood J, Adamson P, Wavre-Shapton ST, Moss SE, Hayes MJ. Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina. Molecular Biology of the Cell. 20: 3896-904. PMID 19587120 DOI: 10.1091/mbc.E08-12-1204  0.72
2008 He KL, Deora AB, Xiong H, Ling Q, Weksler BB, Niesvizky R, Hajjar KA. Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11. The Journal of Biological Chemistry. 283: 19192-200. PMID 18434302 DOI: 10.1074/jbc.M800100200  0.72
2007 Tanaka Y, Ishii H, Hiraoka M, Miyasaka N, Kuroiwa T, Hajjar KA, Nagaoka T, Duong TQ, Ohno K, Yoshida M. Efficacy of recombinant annexin 2 for fibrinolytic therapy in a rat embolic stroke model: a magnetic resonance imaging study. Brain Research. 1165: 135-43. PMID 17651708 DOI: 10.1016/j.brainres.2007.06.039  0.72
2006 Cesarman-Maus G, Ríos-Luna NP, Deora AB, Huang B, Villa R, Cravioto Mdel C, Alarcón-Segovia D, Sánchez-Guerrero J, Hajjar KA. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood. 107: 4375-82. PMID 16493010 DOI: 10.1182/blood-2005-07-2636  0.72
2006 Ballard VL, Sharma A, Duignan I, Holm JM, Chin A, Choi R, Hajjar KA, Wong SC, Edelberg JM. Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 717-9. PMID 16461331 DOI: 10.1096/fj.05-5131fje  0.72
2005 Cesarman-Maus G, Hajjar KA. Molecular mechanisms of fibrinolysis. British Journal of Haematology. 129: 307-21. PMID 15842654 DOI: 10.1111/j.1365-2141.2005.05444.x  0.72
2005 Cesarman-Maus G, Hajjar KA. Annexin checks in - Response to Waisman [3] British Journal of Haematology. 131: 554-556. DOI: 10.1111/j.1365-2141.2005.05806.x  0.72
2004 Deora AB, Kreitzer G, Jacovina AT, Hajjar KA. An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface Journal of Biological Chemistry. 279: 43411-43418. PMID 15302870 DOI: 10.1074/jbc.M408078200  0.72
2004 Ling Q, Jacovina AT, Deora A, Febbraio M, Simantov R, Silverstein RL, Hempstead B, Mark WH, Hajjar KA. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. The Journal of Clinical Investigation. 113: 38-48. PMID 14702107 DOI: 10.1172/JCI19684  0.72
2004 Krishnan S, Deora AB, Annes JP, Osoria J, Rifkin DB, Hajjar KA. Annexin II-mediated plasmin generation activates TGF-beta3 during epithelial-mesenchymal transformation in the developing avian heart. Developmental Biology. 265: 140-54. PMID 14697359 DOI: 10.1016/j.ydbio.2003.08.026  0.72
2004 Brownstein C, Deora AB, Jacovina AT, Weintraub R, Gertler M, Khan KM, Falcone DJ, Hajjar KA. Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages. Blood. 103: 317-24. PMID 14504107 DOI: 10.1182/blood-2003-04-1304  0.72
2003 Markle RA, Han J, Summers BD, Yokoyama T, Hajjar KA, Hajjar DP, Gotto AM, Nicholson AC. Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells. Journal of Cellular Biochemistry. 90: 23-32. PMID 12938153 DOI: 10.1002/jcb.10602  0.72
2002 Arzimanoglou II, Hansen LL, Chong D, Li Z, Psaroudi MC, Dimitrakakis C, Jacovina AT, Shevchuk M, Reid L, Hajjar KA, Vassilaros S, Michalas S, Gilbert F, Chervenak FA, Barber HR. Frequent LOH at hMLH1, a highly variable SNP in hMSH3, and negligible coding instability in ovarian cancer. Anticancer Research. 22: 969-75. PMID 12014680  0.72
2002 Kim J, Hajjar KA. Annexin II: a plasminogen-plasminogen activator co-receptor. Frontiers in Bioscience : a Journal and Virtual Library. 7: d341-8. PMID 11815288  0.72
2001 Ishii H, Yoshida M, Hajjar KA, Tanaka A, Yasukochi Y, Shimokado K, Numano F. Potential role of recombinant annexin II in diabetic vascular injury Annals of the New York Academy of Sciences. 947: 308-311. PMID 11795280  0.72
2001 Brownstein C, Falcone DJ, Jacovina A, Hajjar KA. A mediator of cell surface-specific plasmin generation Annals of the New York Academy of Sciences. 947: 143-156. PMID 11795262  0.72
2001 Ishii H, Yoshida M, Hiraoka M, Hajjar KA, Tanaka A, Yasukochi Y, Numano F. Recombinant annexin II modulates impaired fibrinolytic activity in vitro and in rat carotid artery Circulation Research. 89: 1240-1245. PMID 11739291  0.72
2001 Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, ... ... Hajjar KA, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Medicine. 7: 1194-201. PMID 11689883 DOI: 10.1038/nm1101-1194  0.72
2001 Jacovina AT, Zhong F, Khazanova E, Lev E, Deora AB, Hajjar KA. Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. The Journal of Biological Chemistry. 276: 49350-8. PMID 11679580 DOI: 10.1074/jbc.M106289200  0.72
2001 Meneses PI, Hajjar KA, Berns KI, Duvoisin RM. Recombinant angiostatin prevents retinal neovascularization in a murine proliferative retinopathy model. Gene Therapy. 8: 646-8. PMID 11320411 DOI: 10.1038/sj.gt.3301423  0.72
2001 Hajjar KA. Homocysteine: A sulph'rous fire Journal of Clinical Investigation. 107: 663-664. PMID 11254663  0.72
2001 Falcone DJ, Borth W, Khan KMF, Hajjar KA. Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II Blood. 97: 777-784. PMID 11157497 DOI: 10.1182/blood.V97.3.777  0.72
2000 Hajjar KA, Deora A. New concepts in fibrinolysis and angiogenesis Current Atherosclerosis Reports. 2: 417-421. PMID 11122773  0.72
2000 Ishii H, Yoshida M, Hajjar KA, Yasukochi Y, Numano F. Construction of recombinant adenoviral vector of annexin II Annals of the New York Academy of Sciences. 902: 311-314. PMID 10865854  0.72
2000 Hajjar KA, Acharya SS. Annexin II and regulation of cell surface fibrinolysis Annals of the New York Academy of Sciences. 902: 265-271. PMID 10865846  0.72
2000 Ma K, Simantov R, Zhang JC, Silverstein R, Hajjar KA, McCrae KR. High affinity binding of β2-glycoprotein I to human endothelial cells is mediated by annexin II Journal of Biological Chemistry. 275: 15541-15548. PMID 10809787 DOI: 10.1074/jbc.275.20.15541  0.72
2000 Ling Q, Hajjar KA. Inhibition of endothelial cell thromboresistance by homocysteine Journal of Nutrition. 130. PMID 10721910  0.72
1999 Hajjar KA, Krishnan S. Annexin II: A mediator of the plasmin/plasminogen activator system Trends in Cardiovascular Medicine. 9: 128-138. PMID 10639727 DOI: 10.1016/S1050-1738(99)00020-1  0.72
1999 Meneses PI, Abrey LE, Hajjar KA, Gultekin SH, Duvoisin RM, Berns KI, Rosenfeld MR. Simplified production of a recombinant human angiostatin derivative that suppresses intracerebral glial tumor growth. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 5: 3689-94. PMID 10589788  0.72
1999 Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, Hajjar KA. Annexin II and bleeding in acute promyelocytic leukemia. The New England Journal of Medicine. 340: 994-1004. PMID 10099141 DOI: 10.1056/NEJM199904013401303  0.72
1998 Hajjar KA, Jacovina AT. Modulation of annexin II by homocysteine: implications for atherothrombosis. Journal of Investigative Medicine : the Official Publication of the American Federation For Clinical Research. 46: 364-9. PMID 9805420  0.72
1998 Chacko G, Ling Q, Hajjar KA. Induction of acute translational response genes by homocysteine: Elongation factors-1α, -β, and -δ Journal of Biological Chemistry. 273: 19840-19846. PMID 9677419 DOI: 10.1074/jbc.273.31.19840  0.72
1998 Camera M, Hajjar KA, Pan S, Szabo P, Vicart P, Paulin D, Weksler BB. Profibrinolytic properties characterize a stably transformed human endothelial cell line Blood Coagulation and Fibrinolysis. 9: 153-165. PMID 9622213  0.72
1998 Hajjar KA, Mauri L, Jacovina AT, Zhong F, Mirza UA, Padovan JC, Chait BT. Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine. The Journal of Biological Chemistry. 273: 9987-93. PMID 9545344 DOI: 10.1074/jbc.273.16.9987  0.72
1997 Hajjar KA, Menell JS. Annexin II: A novel mediator of cell surface plasmin generation Annals of the New York Academy of Sciences. 811: 337-349. PMID 9186609 DOI: 10.1111/j.1749-6632.1997.tb52013.x  0.72
1997 Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Alyonycheva TN, Safier LB, Hajjar KA, Posnett DN, Schoenborn MA, Schooley KA, Gayle RB, Maliszewski CR. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. The Journal of Clinical Investigation. 99: 1351-60. PMID 9077545 DOI: 10.1172/JCI119294  0.72
1997 Mitra D, Jaffe EA, Weksler B, Hajjar KA, Soderland C, Laurence J. Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells Blood. 89: 1224-1234. PMID 9028945  0.72
1996 Hajjar KA, Nachman RL. The role of lipoprotein(a) in atherogenesis and thrombosis Annual Review of Medicine. 47: 423-442. PMID 8712793 DOI: 10.1146/annurev.med.47.1.423  0.72
1996 Hajjar KA, Guevara CA, Lev E, Dowling K, Chacko J. Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface. Essential role of endonexin repeat 2 Journal of Biological Chemistry. 271: 21652-21659. PMID 8702954 DOI: 10.1074/jbc.271.35.21652  0.72
1995 Hajjar KA. Changing concepts in fibrinolysis Current Opinion in Hematology. 2: 345-350. PMID 9372018  0.72
1995 Hajjar KA. Cellular receptors in the regulation of plasmin generation Thrombosis and Haemostasis. 74: 294-301. PMID 8578475  0.72
1995 Marcus AJ, Safier LB, Broekman MJ, Islam N, Fliessbach JH, Hajjar KA, Kaminski WE, Jendraschak E, Silverstein RL, Von Schacky C. Thrombosis and inflammation as multicellular processes: Significance of cell-cell interactions Thrombosis and Haemostasis. 74: 213-217. PMID 8578460  0.72
1995 Marcus AJ, Safier LB, Kaminski WE, Islam N, Hajjar KA, Jendraschak E, Silverstein RL, Broekman MJ, von Schacky C, Fliessbach JH. Principles of thromboregulation: control of platelet reactivity in vascular disease Advances in Prostaglandin, Thromboxane, and Leukotriene Research. 23: 413-418. PMID 7732885  0.72
1994 Hajjar KA, Reynolds CM. α-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells Journal of Clinical Investigation. 93: 703-710. PMID 8113404  0.72
1994 Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation Journal of Biological Chemistry. 269: 21198-21203. PMID 8063741  0.72
1994 Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. The Journal of Biological Chemistry. 269: 21191-7. PMID 8063740  0.72
1994 Hajjar KA. Factor V Leiden - An unselfish gene? New England Journal of Medicine. 331: 1585-1587. PMID 7969330 DOI: 10.1056/NEJM199412083312310  0.72
1993 Shih GC, Hajjar KA. Plasminogen and Plasminogen Activator Assembly on the Human Endothelial Cell Proceedings of the Society For Experimental Biology and Medicine. 202: 258-264. PMID 8437979 DOI: 10.3181/00379727-202-43534A  0.72
1993 Hajjar KA. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor Journal of Clinical Investigation. 91: 2873-2879. PMID 8390492  0.72
1992 Douglas PS, Clarkson TB, Flowers NC, Hajjar KA, Horton E, Klocke FJ, LaRosa J, Shively C. Exercise and atherosclerotic heart disease in women. Medicine and Science in Sports and Exercise. 24: S266-76. PMID 1625552  0.72
1992 Hajjar KA. What are current approaches to studying lipoprotein metabolism as it relates to thrombosis? American Journal of Clinical Nutrition. 56. PMID 1414983  0.72
1992 Hajjar KA. Assembly of plasmin-generating proteins on the surface of human endothelial cells Annals of Epidemiology. 2: 419-426. PMID 1342292 DOI: 10.1016/1047-2797(92)90091-4  0.72
1991 Marcus AJ, Safier LB, Hajjar KA, Ullman HL, Islam N, Broekman MJ, Eiroa AM. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells. The Journal of Clinical Investigation. 88: 1690-6. PMID 1939654 DOI: 10.1172/JCI115485  0.72
1991 Nachman RL, Hajjar KA. Endothelial cell fibrinolytic assembly Annals of the New York Academy of Sciences. 614: 240-249. PMID 1902639 DOI: 10.1016/0741-5214(90)90119-U  0.72
1991 Etingin OR, Hajjar DP, Hajjar KA, Harpel PC, Nachman RL. Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells: A potential mechanism in thrombogenesis Journal of Biological Chemistry. 266: 2459-2465. PMID 1824942  0.72
1991 Hajjar KA. The endothelial cell tissue plasminogen activator receptor: Specific interaction with plasminogen Journal of Biological Chemistry. 266: 21962-21970. PMID 1657983  0.72
1990 Hajjar KA, Hamel NM. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase Journal of Biological Chemistry. 265: 2908-2916. PMID 2154465  0.72
1989 Hajjar DP, Nicholson AC, Hajjar KA, Sando GN, Summers BD. Decreased messenger RNA translation in herpesvirus-infected arterial cells: effects on cholesteryl ester hydrolase. Proceedings of the National Academy of Sciences of the United States of America. 86: 3366-70. PMID 2541444  0.72
1989 Hajjar KA, Gavishi D, Breslow JL, Nachman RL. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis Nature. 339: 303-305. PMID 2524666  0.72
1988 Hajjar KA, Nachman RL. Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface Journal of Clinical Investigation. 82: 1769-1778. PMID 3141482  0.72
1988 Hajjar DP, Marcus AJ, Pomerantz KB, Hajjar KA. Arterial cell interactions: mechanistic studies related to eicosanoid and growth factor-induced alterations in cholesterol metabolism. Advances in Experimental Medicine and Biology. 243: 37-45. PMID 3066186  0.72
1988 Staiano-Coico L, Hajjar DP, Hefton JM, Hajjar KA, Kimmel M. Interactions of arterial cells: III. Stathmokinetic analyses of smooth muscle cells cocultured with endothelial cells Journal of Cellular Physiology. 134: 485-490. PMID 2450881  0.72
1988 Hajjar DP, Marcus AJ, Hajjar KA. Arterial endothelial cell-derived eicosanoids alter cholesterol metabolism in arterial smooth muscle cells Annals of the New York Academy of Sciences. 524: 411-413.  0.72
1987 Hajjar KA, Hajjar DP, Silverstein RL, Nachman RL. Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells Journal of Experimental Medicine. 166: 235-245. PMID 3598461  0.72
1987 Hajjar DP, Marcus AJ, Hajjar KA. Interactions of arterial cells. Studies on the mechanisms of endothelial cell modulation of cholesterol metabolism in co-cultured smooth muscle cells. The Journal of Biological Chemistry. 262: 6976-81. PMID 3294823  0.72
1987 Hajjar KA, Hamel NM, Harpel PC, Nachman RL. Binding of tissue plasminogen activator to cultured human endothelial cells Journal of Clinical Investigation. 80: 1712-1719. PMID 3119664  0.72
1986 Hajjar KA, Harpel PC, Jaffe EA, Nachman RL. Binding of plasminogen to cultured human endothelial cells Journal of Biological Chemistry. 261: 11656-11662. PMID 3745161  0.72
1986 Nachman RL, Hajjar KA, Silverstein RL, Dinarello CA. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor Journal of Experimental Medicine. 163: 1595-1600. PMID 3086483  0.72
1985 Hajjar KA. Structural and functional analysis of spectrin from neonatal erythrocytes Biochimica Et Biophysica Acta (Bba)/Protein Structure and Molecular. 827: 460-465. PMID 3970945 DOI: 10.1016/0167-4838(85)90233-X  0.72
1985 Hajjar KA. Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Following Apparent Acute Lymphoblastic Leukemia Clinical Pediatrics. 24: 402-405. PMID 3859395 DOI: 10.1177/000992288502400710  0.72
Show low-probability matches.